Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [579]
News [1092]
Articles [59]
Editorials [2]
Conferences [100]
elearning [5]
New drug demonstrates early promise in metastatic breast cancer
Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio...
New drug demonstrates early promise in metastatic breast cancer ( Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio, USA )
1 May 2014
New tools can help tackle flawed decision-making process for HER2- patients
Dr Matti Aapro - Multidisciplinary Oncology Institute, Clinique De Genolier...
New tools can help tackle flawed decision-making process for HER2- patients ( Dr Matti Aapro - Multidisciplinary Oncology Institute, Clinique De Genolier, Switzerland )
4 Apr 2014
Genetic testing can improve selection of women with ER positive breast cancer...
Prof Mitch Dowsett - The Institute of Cancer Research, London, UK
Genetic testing can improve selection of women with ER positive breast cancer for ten rather than five years of hormonal therapy ( Prof Mitch Dowsett - The Institute of Cancer Research, London, UK )
1 Apr 2014
EBCC 2014 key messages to doctors
Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK
EBCC 2014 key messages to doctors ( Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK )
1 Apr 2014
Ganetespib in first-line treatment of women with metastatic HER2 positive or...
Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK
Ganetespib in first-line treatment of women with metastatic HER2 positive or triple negative breast cancer ( Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK )
1 Apr 2014
mCRPC management in Taiwan - expert interview
Prof Paul de Souza and Dr Wayne Yen-Hwa Chang
mCRPC management in Taiwan - expert interview ( Prof Paul de Souza and Dr Wayne Yen-Hwa Chang )
21 Mar 2014
The future of mCRPC treatment - expert discussion
Prof Li Ping Xie - Zhejiang University School of Medicine, Hangzhou, China and...
The future of mCRPC treatment - expert discussion ( Prof Li Ping Xie - Zhejiang University School of Medicine, Hangzhou, China and Prof Paul de Souza - University of Western Sydney, Sydney, Australia )
21 Mar 2014
PSA as a marker of disease in patients with prostate cancer and bone metastases
Prof Laurence Koltz, Prof Wolfgang Horninger, Prof Bertrand Tombal
PSA as a marker of disease in patients with prostate cancer and bone metastases ( Prof Laurence Koltz, Prof Wolfgang Horninger, Prof Bertrand Tombal )
28 Feb 2014
Predictive power of PSA patterns during off-time treatment periods with...
Dr Rafael Sanchez-Salas - Institut Mutualiste Montsouris, Paris, France
Predictive power of PSA patterns during off-time treatment periods with intermittent androgen deprivation ( Dr Rafael Sanchez-Salas - Institut Mutualiste Montsouris, Paris, France )
1 Feb 2014
Enzalutamide improves survival in men with metastatic castration-resistant...
Dr Tomasz M. Beer - Oregon Health & Science University, Portland, USA
Enzalutamide improves survival in men with metastatic castration-resistant prostate cancer ( Dr Tomasz M. Beer - Oregon Health & Science University, Portland, USA )
31 Jan 2014
MET variant as a prognostic marker in clear cell renal cell carcinoma
Dr Ari Hakimi - Memorial Sloan-Kettering Cancer Center, New York, USA
MET variant as a prognostic marker in clear cell renal cell carcinoma ( Dr Ari Hakimi - Memorial Sloan-Kettering Cancer Center, New York, USA )
31 Jan 2014
Dissecting the biology of the androgen receptor pathway
Dr Peter Nelson - Fred Hutchinson Cancer Research Center, Seattle, USA
Dissecting the biology of the androgen receptor pathway ( Dr Peter Nelson - Fred Hutchinson Cancer Research Center, Seattle, USA )
30 Jan 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation